Albert David Ltd

Know More

1352.6513.25 (0.99%)

12:00 AM,23rd Feb 2024

1353.1010.10 (0.75%)

12:00 AM,23rd Feb 2024

BSE : 524075


Sector : Health care

ISIN Code : INE155C01010

  • NSE
  • BSE
  • 1D
  • 5D
  • 1M
  • 6M
  • 1Y
  • 2Y
  • 5Y
  • MAX

Last Updated: Feb 23 2024 | 12:00 AM IST

Market Cap (₹ Cr)


Turnover (₹ Cr)


Volume (Shares)


Face Value


52-WK High


52-WK High Date

25 Jan 2024

52-WK Low


52-WK Low Date

31 Mar 2023

All Time High


All Time High Date

25 Jan 2024

All Time Low


All Time Low Date

23 Mar 2020

Albert David Ltd

Albert David Limited (ADL) a Unit of Kothari Group was incorporated in 1938 at Calcutta. The Company belongs to a renowned industrial house of Kolkata the Kothari Group. The Company's principal business is manufacturing and trading of Pharmaceutical Formulations Infusion Solutions Herbal Dosage Forms and Bulk Drugs by way of domestic sale or export. Apart from these it manufactures disposable syringes and needles and a wide range of bulk drugs. It is recognised as a large IV fluid manufacturer both in glass and polyethylene containers.ADL has entered into a technical collaboration with Morishita Pharmaceuticals Japan a subsidiary of Ajinomoto -- the world leader in amino acids -- to manufacture amino acid infusions for which it came out with a rights issue in Aug.'87. It has also set up a new unit in Kalyani West Bengal to manufacture bulk drugs which went on stream in 1990. Another rights issue in Mar.'90 augmented the long-term working capital. ADL has entered into technical collaboration with Pharma Plan Germany to supply machinery to manufacture 30 mln disposable syringes and 70 mln needles at Mandideep near Bhopal. ADL came up with a Rs 4.68-cr right issue to part finance the expansion of its capacity of IV fluids in plastic bottles (FFS technology) at Ghaziabad.During 1998-99 the company has developed some new products viz. Siozole Capsules and Ferrochelate-Z-Capsules with Iron & Zinc and folic acid in sustained released formulation. In 2002-03 the company has launched new products-INTECARNIMERIL-TEVICTALROF-50. It is also planning to launch new products such as SIOOXYALAMIN FEZPANSURE.New products were launched such as - INTECAR Capsules NIMERIL-T EVICT ALROF-50 ADLIN and SLOZIN during the year 2003; new products such as Alamin-FeZ and Pansure were introduced in 2004. SIOOXY (Anti-Oxidant with OMEGA-3 Fatty Acid) was launched in 2005 launched ALAMTN-Xtra VERBET - the antivertigo drug and water for injection during year 2006; launched Antibiotic Azithromycin under brand 'AZ3' and expanded its Vision Care range (launched Antiglaucoma products Antiinfectives Irrigating Solution and Steroidal combinations) in 2009; launched uterine tonic-Siocare and Laxative combination-Evict Fibre and has also expanded its Anti-inflammatory & Analgesic range with launch of Anaflam XP in 2010; launched Rabeprazole and its combination (Anti-Peptic Ulcerant range) and Montelukast and its combination (Anti Asthmatic range) in 2013; launched Alamin Liquid and Alamin RLD (L-Arginine Sachet) in 2014; launched Dhup Tab & Drop (Vit.D3) Inbalanse-Z (probiotic) and Evict-XF (Laxative) in 2015; launched Sioneuron M/PG capsules Inbalanse-Z capsules and Breaze-Fx tablet in 2017. It introduced two products i.e. Evacure and C3H in the market during year 2021-22.

Albert David Ltd - Key Fundamentals

Market Cap (₹ Cr)


EPS - TTM (₹) [S]


P/E Ratio (X) [S]


Face Value (₹) 10
Latest Dividend (%)90.00
Latest Dividend Date 03 Aug 2023
Dividend Yield (%) 0.67
Book Value Share (₹) [S]613.47
P/B Ratio (₹) [S]2.20
[*C] Consolidated [*S] Standalone

Funds Owing this Stock

Scheme Name Amount Invested ( ₹ Cr ) No Of Shares Net Asset (%)
Motilal Oswal S&P BSE Healthcare ETF 0.00 23 0.02

Research Reports

Date BrokerActionPrices(Rs)Report
Data Not Found

Stock Strength

Today's Low/High



Week Low/High



Month Low/High



Year Low/High



All time Low/High



Share Price Returns

1 Week-3.62%-4.45%1.290.78%
1 Month4.47%4.75%4.244.59%
3 Month41.85%41.75%11.1212.17%
6 Month75.30%75.13%12.1114.24%
1 Year141.54%141.76%23.0726.85%
3 Year241.19%241.58%47.4551.03%

Company Info

Company Information

Executive Chairman : A K Kothari

Independent Director : Hemal Kampani

Independent Director : Rajiv Singhi

Director : Prabhawati Devi Kothari

Independent Director : Arindam Sarkar

Independent Director : Shirish Gundopant Belapure

Independent Director : Monjori Mitra

Director : Anand Vardhan Kothari

Company Sec. & Compli. Officer : A B Chakrabarty

Managing Director & CEO : U. M. Kunte

Registered Office: D Block 3rd Flr Gillander Hous, Netaji Subhas Road,Kolkata,West Bengal-700001 Ph: 91-33-22302330/2262 8436/8456/